B-hALB plus/hFcRn mice
| Strain Name |
C57BL/6-Albtm2(ALB)BcgenFcgrttm1(FCGRT)Bcgen/Bcgen
|
Common Name | B-hALB plus/hFcRn mice |
| Background | C57BL/6 | Catalog number |
113043 |
|
Related Genes |
FT, HSA, PRO0883, PDAHRO0903, PRO1341; FCRN, FcgammaRn, alpha-chain
|
||
|
NCBI Gene ID |
213, 2217 | ||
Model validation
Targeting strategy
Protein expression analysis
Determination of plasma concentrations of Ozoralizumab analog in different mice
Gene targeting strategy for B-hALB plus/hFcRn mice.The coding sequence of the full-length human ALB protein was inserted to replaced part of murine exon 1 in B-hALB plus/hFcRn mice.The human full-length FCGRT cDNA sequence was inserted in the Fcgrt exon2 of B-hALB plus/hFcRn mice.
Strain specific albumin expression analysis in homozygous B-hALB plus/hFcRn mice by ELISA. Serum was collected from wild-type C57BL/6JNifdc mice (+/+) and homozygous B-hALB plus/hFcRn mice (H/H), and analyzed by ELISA with species-specific albumin ELISA kit (Mouse Albumin ELISA Kit, abcam, ab207620; Human Albumin ELISA Kit, abcam, ab179887). Mouse ALB was detectable in wild-type mice. Human ALB was exclusively detectable in homozygous B-hALB plus/hFcRn mice but not in wild-type mice.
Pharmacokinetic characteristic of wild-type C57BL/6JNifdc mice and homozygous B-hALB plus/hFcRn mice. C57BL/6JNifdc mice and homozygous B-hALB plus/hFcRn mice were injected intravenously with Ozoralizumab analog (in-house) at time 0 (n=12). Blood samples were collected at different time point for the PK assay. The half-life of Ozoralizumab analog (in-house) in B-hALB plus/hFcRn mice is longer than that in wild-type C57BL/6JNifdc mice, indicating that the albumin in B-hALB plus/hFcRn mice plays a role. This antibody can recognize both MSA (mouse serum albumin) and HSA (human serum albumin), leading to the speculation that its affinity for HSA would be higher than for MSA.
Technical support
Quality Assurance
+86-10-56967680
info@bbctg.com.cn
Copyright © 2024 BioMice. All Rights Reserved
Powered by Fractal-technology